JF
DCPH

Jump Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jump Financial’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,375
Closed -$522K – 2408
2023
Q4 		$522K Buy
+32,375
New +$413K 0.02% 1039
2023
Q1 		– Sell
-44,962
Closed -$737K – 2149
2022
Q4 		$737K Sell
44,962
-18,968
-30% -$308K 0.04% 616
2022
Q3 		$1.18M Buy
+63,930
New +$1M 0.05% 556

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Jump Financial's DCPH Position: Q1 2024 in Review

Jump Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 32,375 shares — an estimated $522K sold.

Jump Financial first reported a position in DCPH in Q3 2022 and held it in 3 quarters. The position peaked at $1.18M in Q3 2022. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Jump Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jump Financial sold 32,375 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $522K.
  • Jump Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Jump Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.18M in Q3 2022.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.